C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population

To determine whether fasting C-peptide is an independent predictor for non-alcoholic fatty liver disease (NAFLD) in United States population. Using the National Health and Nutrition Examination Survey (NHANES) 1988-1994, NAFLD participants aged 20 or greater without any other liver diseases were inc...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 24; no. 32; pp. 3663 - 3670
Main Authors Atsawarungruangkit, Amporn, Chenbhanich, Jirat, Dickstein, George
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 28.08.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To determine whether fasting C-peptide is an independent predictor for non-alcoholic fatty liver disease (NAFLD) in United States population. Using the National Health and Nutrition Examination Survey (NHANES) 1988-1994, NAFLD participants aged 20 or greater without any other liver diseases were included in this study. Excessive alcohol intake is defined as > 2 drinks per day for males and > 1 drink per day for females. C-peptide and 27 other factors known to be associated with NAFLD ( ., age, gender, body mass index, waist circumference, race/ethnicity, liver chemistries, and other diabetes tests) were tested in both univariate and multivariate level using logistic regression with a -value 0.05. Of 18825 participants aged ≥ 20, 3235 participants ( = 3235) met inclusion criteria. There were 23 factors associated with NAFLD by univariate analysis. 9 factors, ranked by the highest change in pseudo , were found to be significant predictors of NAFLD in multivariate model: waist circumference, fasting C-peptide, natural log of alanine aminotransferase (ALT), total protein, being Mexican American, natural log of glycated hemoglobin, triglyceride level, being non-Hispanic white, and ferritin level. Together with waist circumference and ALT, fasting C-peptide is among three most important predictors of NAFLD in United States population in the NHANES data set. Further study is needed to validate the clinical utility of fasting C-peptide in diagnosis or monitoring insulin resistance in NAFLD patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Telephone: +1-857-3126114
Correspondence to: Amporn Atsawarungruangkit, BPharm, MD, Doctor, Research Fellow, Department of Medicine, MetroWest Medical Center, 115 Lincoln St., Framingham, MA 01702, United States. a.atsawarungraungkit.@mwmc.com
Author contributions: Atsawarungruangkit A contributed to the study concept and design, analysis and interpretation of data, and preparation of manuscript; Chenbhanich J and Dickstein G contributed to interpretation of data and preparation and manuscript; all authors read and approved the final manuscript.
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v24.i32.3663